SUPN Kronos AI forecast
A 30-trading-day price forecast for Supernus Pharmaceuticals Inc. (SUPN) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Supernus Pharmaceuticals Inc. at $44.35 on 2026-12-08, +8.3% from the last close of $40.96 on 2026-10-27. Eight out of ten sampled paths end between $43.35 and $48.15, and 8 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of SUPN
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $40.79 | $40.32 | $42.96 |
| 2026-11-10 | $42.37 | $42.00 | $43.28 |
| 2026-11-17 | $43.73 | $43.09 | $44.77 |
| 2026-11-24 | $44.44 | $43.28 | $46.40 |
| 2026-12-01 | $44.74 | $43.03 | $46.60 |
| 2026-12-08 | $44.35 | $43.35 | $48.15 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for SUPN?
- Kronos AI's median forecast for SUPN is $44.35 in 30 trading days, +8.3% from the last close, with a 10–90% range of $43.35 to $48.15.
- Is the SUPN Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC